RM
INSIDER · UTHR · UNITED THERAPEUTICS Corp · CHAIRPERSON & CEO
ROTHBLATT MARTINE A
Every open-market transaction filed under this name, Aug 19 to Sep 3.
Filings
134
0 buys · 134 sells
Bought
—
open market, at cost
Sold
$58.5M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 42 | $491.25 | $21K | −0.7% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 940 | $490.50 | $461K | −0.6% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 3,114 | $489.62 | $1.5M | −0.4% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,604 | $488.68 | $784K | −0.2% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,429 | $487.87 | $697K | −0.1% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 411 | $486.72 | $200K | +0.2% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $485.16 | $116K | +0.5% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $483.69 | $39K | +0.8% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $482.35 | $193K | +1.1% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 600 | $481.47 | $289K | +1.3% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 440 | $480.53 | $211K | +1.5% |
| Sep 3 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $479.07 | $96K | +1.8% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $510.05 | $82K | −4.4% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $508.36 | $41K | −4.1% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $506.27 | $20K | −3.7% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $505.20 | $20K | −3.5% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $504.15 | $101K | −3.3% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $502.01 | $60K | −2.9% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $501.06 | $80K | −2.7% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 54 | $500.22 | $27K | −2.5% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 542 | $498.97 | $270K | −2.3% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 364 | $498.21 | $181K | −2.1% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 777 | $496.95 | $386K | −1.9% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 423 | $495.95 | $210K | −1.7% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 520 | $494.33 | $257K | −1.4% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 520 | $493.59 | $257K | −1.2% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,067 | $492.25 | $1M | −0.9% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,833 | $491.38 | $901K | −0.8% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 560 | $490.19 | $275K | −0.5% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $489.06 | $117K | −0.3% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $486.32 | $78K | +0.3% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $485.12 | $58K | +0.5% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $482.61 | $39K | +1.0% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $479.89 | $77K | +1.6% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 160 | $478.85 | $77K | +1.8% |
| Sep 2 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $477.70 | $57K | +2.1% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $516.62 | $41K | −5.6% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,469 | $516.03 | $758K | −5.5% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,620 | $514.98 | $834K | −5.3% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 3,454 | $514.09 | $1.8M | −5.2% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,732 | $513.12 | $889K | −5.0% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 825 | $511.95 | $422K | −4.8% |
| Sep 1 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 320 | $510.72 | $163K | −4.5% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $514.96 | $21K | −5.3% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 762 | $514.32 | $392K | −5.2% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 678 | $513.50 | $348K | −5.0% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,600 | $511.75 | $819K | −4.7% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 4,217 | $510.93 | $2.2M | −4.6% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 810 | $509.84 | $413K | −4.4% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 794 | $508.92 | $404K | −4.2% |
| Aug 31 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 599 | $507.84 | $304K | −4.0% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $524.42 | $105K | −7.0% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 6 | $523.42 | $3K | −6.8% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 517 | $522.40 | $270K | −6.7% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 286 | $521.58 | $149K | −6.5% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 751 | $520.30 | $391K | −6.3% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 412 | $519.19 | $214K | −6.1% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,346 | $518.14 | $697K | −5.9% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,486 | $517.11 | $768K | −5.7% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,386 | $516.16 | $1.2M | −5.5% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,630 | $515.46 | $840K | −5.4% |
| Aug 28 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 480 | $514.26 | $247K | −5.2% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $531.12 | $64K | −8.2% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 755 | $530.08 | $400K | −8.0% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,308 | $529.15 | $692K | −7.9% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,237 | $528.29 | $654K | −7.7% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $526.37 | $147K | −7.4% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 376 | $525.62 | $198K | −7.2% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 744 | $524.61 | $390K | −7.1% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $523.60 | $126K | −6.9% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $522.40 | $146K | −6.7% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 477 | $521.24 | $249K | −6.5% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,003 | $520.23 | $522K | −6.3% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $518.89 | $104K | −6.0% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 280 | $517.07 | $145K | −5.7% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $515.33 | $124K | −5.4% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 120 | $514.32 | $62K | −5.2% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 704 | $513.40 | $361K | −5.0% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 642 | $512.47 | $329K | −4.9% |
| Aug 27 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 494 | $511.58 | $253K | −4.7% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 40 | $521.48 | $21K | −6.5% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 400 | $520.62 | $208K | −6.3% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 476 | $519.35 | $247K | −6.1% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,790 | $518.35 | $928K | −5.9% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 3,516 | $517.49 | $1.8M | −5.8% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,128 | $516.70 | $583K | −5.6% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,591 | $515.41 | $820K | −5.4% |
| Aug 26 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 559 | $514.64 | $288K | −5.3% |
| Aug 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $520.50 | $42K | −6.3% |
| Aug 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 668 | $519.91 | $347K | −6.2% |
| Aug 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,387 | $518.80 | $1.2M | −6.0% |
| Aug 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,004 | $518.08 | $1M | −5.9% |
| Aug 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,332 | $516.95 | $1.2M | −5.7% |
| Aug 25 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,029 | $516.12 | $1M | −5.5% |
| Aug 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,305 | $513.35 | $670K | −5.0% |
| Aug 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 3,592 | $512.46 | $1.8M | −4.8% |
| Aug 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 3,056 | $511.63 | $1.6M | −4.7% |
| Aug 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,323 | $510.52 | $675K | −4.5% |
| Aug 24 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 224 | $509.41 | $114K | −4.3% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $527.71 | $106K | −7.6% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 45 | $526.47 | $24K | −7.4% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 235 | $525.42 | $123K | −7.2% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 625 | $524.35 | $328K | −7.0% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 455 | $523.62 | $238K | −6.9% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 669 | $522.29 | $349K | −6.6% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 371 | $521.28 | $193K | −6.5% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 440 | $520.03 | $229K | −6.2% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 837 | $519.09 | $434K | −6.1% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,077 | $518.14 | $558K | −5.9% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 773 | $517.07 | $400K | −5.7% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,689 | $516.15 | $872K | −5.5% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 624 | $515.26 | $322K | −5.4% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 271 | $513.85 | $139K | −5.1% |
| Aug 21 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,189 | $512.71 | $610K | −4.9% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 193 | $526.97 | $102K | −7.5% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $525.10 | $126K | −7.1% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 800 | $523.26 | $419K | −6.8% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 960 | $522.37 | $501K | −6.7% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,470 | $521.39 | $1.3M | −6.5% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,357 | $520.46 | $1.2M | −6.3% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,504 | $519.51 | $781K | −6.1% |
| Aug 20 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 976 | $518.45 | $506K | −5.9% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $535.22 | $43K | −8.9% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 200 | $532.63 | $107K | −8.5% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 80 | $531.62 | $43K | −8.3% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 201 | $531.01 | $107K | −8.2% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 659 | $529.56 | $349K | −7.9% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,200 | $528.59 | $634K | −7.8% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,135 | $527.58 | $1.1M | −7.6% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 2,105 | $526.76 | $1.1M | −7.4% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 895 | $525.60 | $470K | −7.2% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 441 | $524.51 | $231K | −7.0% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 1,264 | $523.65 | $662K | −6.9% |
| Aug 19 | UTHR | UNITED THERAPEUTICS Corp | Chairperson & CEO | Sell | 240 | $522.49 | $125K | −6.7% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.